Status:

RECRUITING

Autologous Testicular Tissue Transplantation

Lead Sponsor:

Universitair Ziekenhuis Brussel

Collaborating Sponsors:

Vrije Universiteit Brussel

Conditions:

Cancer

Sickle Cell Thalassemia

Eligibility:

MALE

18-50 years

Phase:

NA

Brief Summary

Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells (SSCs) in case of imminent gonadotoxic treatment during childhood. In case of total azoospermia in a...

Detailed Description

Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells (SSCs). In 2002, the University hospital in Brussels (UZB) was the first hospital worldwide to offer...

Eligibility Criteria

Inclusion

  • The eligible patients opted as a prepubertal boy to enroll in the fertility preservation program and on the moment of cancer diagnosis or hematological disorder, their parents have agreed to cryopreserve testicular tissue for later autologous transplantation.
  • Inclusion Criteria:
  • At least 18 years old
  • Desire to become a parent at the moment of intake
  • Stable relationship with a female partner and minimal one year cohabiting
  • Age of female partner \< 43 year
  • Azoospermia on 2 semen analyses
  • Normal standardised preliminary and preoperative bloodsampling results
  • Complete remission of the oncological or hematological disease
  • Approval of the treating oncologist or other specialist in case of non-oncological disease as reason for the testicular tissue preservation as a child
  • Risk for presence of malignant cells in testicular tissue is negligible (according to multidisciplinary assessment)
  • Presence of SSCs (positive MAGE staining) in one or two of the thawed fragments (If absence of SSCs in two of the thawed fragments, the case will be discussed multidisciplinary)
  • Written informed consent for the transplantation of cryopreserved testicular tissue and follow-up after the procedure and of children born eventually after this procedure
  • Exclusion criteria:
  • Risk for presence of malignant cells in the testicular tissue
  • Contra-indication for surgery
  • Contra-indication for pregnancy in the female partner
  • BMI \> 32
  • Heavy smoking (≥10 cigarettes/day)
  • Instable psychological condition

Exclusion

    Key Trial Info

    Start Date :

    November 22 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 29 2030

    Estimated Enrollment :

    5 Patients enrolled

    Trial Details

    Trial ID

    NCT05414045

    Start Date

    November 22 2024

    End Date

    October 29 2030

    Last Update

    April 3 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UZ Brussel Centre for Reproductive Medicine

    Brussels, Belgium, 1090